Allylix

Allylix

Allylix has a pipeline of high-value ingredients with commercial applications in flavours, fragrances, cosmetics, food protection, household products and other industrial markets.

Related Articles & Links

November 24, 2014 Evolva acquires Allylix in $59M all-share transaction: what’s the impact for industrial biotech?

December 11, 2014 The Future of Renewable Chemicals

November 18, 2014 Evolva to expand microbial fermentation empire with acquisition of Allylix

September 11, 2013 Substance that Gives Grapefruit Its Flavor and Aroma Could Give Insects the Boot

March 12, 2012 Allylix raises $18.2M, announces launch of new product for fragrance market

March 10, 2011 Flavor firm to capitalize on biotech cost springboard

October 21, 2010 Allylix Sniffs Out Biotech For New Fragrances

August 24, 2010 Interview: Allylix

Our Philosophy

We focus on portfolio returns, big opportunities, high-quality team, and financials that demonstrate a deep understanding of the business. We look for companies where our experience and expertise can add value to produce better outcomes for both entrepreneurs and our investments.

Our Networks

Relationships and people matter. Over the decades, we have developed personal relationships with other quality investors (both Angels and VCs), service providers, and domain experts. If we do not know the answer, we know someone who does.

Our Mentorship

When the company wins, we all win. To maximize success, we often serve as advisors or board members. Both art and science are involved in building a supportive and useful board as well as maintaining solid investor relations. Good financial discipline lays the foundation for success and informs company strategy.

Our Strategy

We like healthcare, especially digital health, but also diagnostics, devices, and bio/genomics. For funding, we often co-invest with other investors and are happy to lead investment rounds. We know term sheets and what drives syndicated investment rounds.
Scroll to top